Skip to main content

Table 3 Characteristics, from review of health record, of patients enrolled compared to all eligible patients

From: Strategies for recruitment and retention of underrepresented populations with chronic obstructive pulmonary disease for a clinical trial

  Enrolled
(n = 192)
Eligible, not enrolled
(n = 90)
P-value
Age, in years, mean (sd) 61.6 (7.6) 65.9 (9.1) p < .01
Male, % (n/N) 68% (125/192) 71% (63/90) p = .42
Primary language other than English, % (n/N) 10.7% (18/169) 8.1% (7/86) p = .52
>  1 hospitalization in 12 months prior to recruitment, % (n/N) 30.2% (58/192) 31.1% (28/90) p = .88
Uses oxygen at home, % (n/N) 6.3% (12/190) 12.2% (11/90) p = .09
Prescription for LAMA or LABA+ICS*, % (n/N) 78.7% (151/192) 84.4% (76/90) p = .25
  1. * LAMA Long-acting muscarinic agent; LABA Long-acting beta-antagonist; ICS Inhaled corticosteroid